Banner Image

Resources

Prescription Drug News of Note - September 2018

Oct 1, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes figures on the prevalence of Diabetes among US adults, new Migraine management products, Vascepa showing reduction in cardiovascular events, and new Hepatitis C generics,.
Read more ▸▸

Prescription Drug News of Note - August 2018

Aug 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of a first-of-its-kind peripheral nerve disease (polyneuropathy) therapy, and the latest on Teva's EpiPen generic
Read more ▸▸

Prescription Drug News of Note - July 2018

Jul 31, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of Tibsovo and Nivestym, and highlights positive results from an Alzheimer's trial
Read more ▸▸

How Healthy Is Your Copay Program? Your Guide to Script Economics

Jul 24, 2018 11:06:27 PM | White Papers, Copay Programs
Is your brand seeing drastic Gross to Net price changes? In this white paper, we cover the basics of script economics and an example of how you can lower copay program costs.
Read more ▸▸

How to Make Smarter Decisions About Your Company’s Prescription Drug Spend

Jul 11, 2018 | Pharmacy Benefit Managers, Enterprise Employers, Trends, Insights & Analysis
As pharmacy benefit costs continue to rise, effective PBM management is needed more than ever. TruBid brings transparency and savings to today’s companies.
Read more ▸▸

Prescription Drug News of Note - June 2018

Jun 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of marijuana-based seizure medication, thoughts on whether OLUMIANT change inflammatory drug pricing, an analysis of Part D spending on brand drugs, and last but not least, Amazon's acquisition of PillPack.
Read more ▸▸

Truveris Expands Audit Capabilities with Launch of TruAudit™

Jun 12, 2018 10:23:56 AM | Press Releases
Truveris announced new audit capabilities geared towards further increasing transparency in the pharmacy benefit space.
Read more ▸▸

Prescription Drug News of Note - May 2018

May 31, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

How a Mid-sized Bank Found Contract Savings with an Existing PBM

May 22, 2018 11:29:40 AM | Case Studies
A mid-sized bank was looking to find a more competitive PBM contract, but didn’t want to change providers. TruBid Express helped them negotiate with their incumbent PBM to secure 21.6% in savings.
Read more ▸▸

Segmenting to Drive a Higher ROI

May 2, 2018 12:06:01 AM |
Read more ▸▸

Trusting the Data

May 1, 2018 11:54:01 PM |
Read more ▸▸

Prescription Drug News of Note - April 2018

Apr 27, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

4 Ways to Tell a Copay Program Vendor from a Copay Program Partner

Apr 16, 2018 | Patient Access Programs, Pharmaceutical Manufacturers, Copay Programs, Trends, Insights & Analysis
Who's at the table for your brand planning sessions?
Read more ▸▸

Truveris to participate in "Can You Afford Your Pharmacy Cost Trend, and How You Can Take Control"

Apr 12, 2018 4:43:45 PM | Events
Our Chief Pharmacy Officer, Alysha Fluno, will participate in an event, titled “Can You Afford Your Pharmacy Cost Trend, and How You Can Take Control,” hosted by The Horton Group.
Read more ▸▸

What Princess Is Your Copay Program?

Apr 3, 2018 | Patient Access Programs, Pharmaceutical Manufacturers, Copay Programs, Trends, Insights & Analysis
If your copay program is underwater, it might be Ariel.
Read more ▸▸

Making Sense of Benefit M&A

Mar 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Pharmacy Benefit Managers
With recent mergers like the Cigna/Express Scripts (ESI) deal, stakeholders across the pharmaceutical industry are curious about the future of independent PBMs, the future of pharmacy carve-out, the opportunity for Truveris, and if/how Amazon can be a catalyst to a major change in the way that we experience, and pay for, healthcare.
Read more ▸▸

Pharma Middlemen Have Targets On Their Backs

Mar 29, 2018 10:48:00 AM | News
What’s a great way for Amazon to prove it can make America’s healthcare system better for consumers? $100 billion of the $500 billion spent on pharmaceuticals in the U.S. is “wasted” on the middleman, said Faisal Mushtaq, CEO of the company Truveris which helps employers choose a PBM to administer their employees’ benefits. He thinks Amazon should “break up the entire business of rebates” that power PBMs, and get rid of the lists of medications called formularies that prescribe what drugs insurers will pay for.
Read more ▸▸

How was Amazon's Wednesday? Depends where you were in Manhattan

Mar 29, 2018 10:28:13 AM | News
At CNBC's Healthy Returns conference, health care types raved about Amazon's potential to disrupt the drug business. “It’s not going to happen tomorrow, but [Amazon] could basically make PBMs irrelevant," Canaan Partners VC Julie Grant said. Data company Truveris CEO Faisal Mushtaq's take: Amazon is "big enough" to replace the health care system's architecture.
Read more ▸▸

Hopes are high for Amazon's entry into health care—as long as they don't 'pull a Facebook'

Mar 28, 2018 5:31:00 PM | News
Amazon can reinvent the drug supply chain and infuse transparency into the health-care system, but it needs to be careful with patient data, panelists said at CNBC's "Healthy Returns" conference. It's no longer a question about whether Amazon is getting into health care, but the tech giant has remained mum on what exactly it's doing. Just the thought of Amazon entering the space has caused the industry to respond, said Truveris CEO Faisal Mushtaq.
Read more ▸▸

Prescription Drug News of Note - March 2018

Mar 27, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Truveris Appoints Sally Welborn, former head of Walmart Global Benefits to Board of Directors

Mar 20, 2018 10:36:44 AM | Press Releases
Truveris announced that Sally Welborn, the former senior vice president of global benefits at Walmart, was elected to the Truveris board of directors.
Read more ▸▸

Using Incentives to Drive Adherence

Mar 12, 2018 4:58:03 PM | Case Studies, Pharmacy Benefit Managers, Patient Access Programs
In a crowded market, one company felt patient adherence was their best option for growth. Truveris added incentives to a new patient access program to help them achieve their goals.
Read more ▸▸

Designing an Affordable Point of Sale Program that Drives Sales

Mar 12, 2018 4:57:30 PM | Case Studies, Patient Access Programs, Copay Programs
Is your point of sale program keeping up with market change? If not, it could be costing you more than it brings in. Learn how Truveris helped a specialty pharmaceutical company increase cost savings without reducing sales.
Read more ▸▸

Jeff Eberle Joins Truveris as Chief Operating Officer

Mar 1, 2018 3:09:12 PM | News
Truveris is excited to announce the addition of COO Jeff Eberle to the team. A business leader with 20 years of experience across all facets of the healthcare industry, Jeff leverages his expertise to spur company growth, strategically plan for the future and monitor financial health.
Read more ▸▸

Prescription Drug News of Note - February 2018

Feb 27, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approvals, Prescription spending trends, and the latest on Albertson's and Rite Aid
Read more ▸▸

Improve Customer Service and Help Patients Understand Cost and Coverage

Feb 23, 2018 1:06:56 PM | Case Studies, Pharmacy Benefit Managers
A leading pharmaceutical company utilized a HUB to help patients and physicians navigate reimbursement and insurance benefits for their top brands.
Read more ▸▸

How Pharmacy Benefit Carve Out Can Help Reduce Benefits Spend

Feb 14, 2018 6:01:33 PM | White Papers, Pharmacy Carve Out, Pharmacy Benefit Managers, Brokers
To help manage that staggering cost, companies are looking for ways to manage their pharmacy benefits. One effective tool for doing so is separating, or “carving out,” prescription drug benefits from major medical plans.
Read more ▸▸

Deductibles and the Consumerization of Healthcare: What Does it Mean for Biopharma Brands?

Feb 7, 2018 | Patient Access Programs, Pharmaceutical Manufacturers, Trends, Insights & Analysis
As consumers are gaining more control over their healthcare spend, here’s what biopharma brands need to consider.
Read more ▸▸

2018 Specialty Drug Trends: What Employers Should Expect

Jan 30, 2018 | Enterprise Employers, Trends, Insights & Analysis, Pharmacy Benefit Managers
Specialty drugs are expensive for employers paying for prescription benefit plans. Learn how to lower costs in 2018 with specialty drug management strategies.
Read more ▸▸

Prescription Drug News of Note - January 2018

Jan 26, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approves 46 Novel Medications in 2017, Hospitals to Start Their Own Generic Drug Company
Read more ▸▸

Is Cutting Costs on Your Copay Program Costing You?

Jan 22, 2018 | Pharmaceutical Manufacturers, Trends, Insights & Analysis, Copay Programs
The long term costs of your copay program’s patient benefit often outweigh the upfront costs of program administrative fees. Here’s what to watch out for.
Read more ▸▸

PBM Contracts: 7 Terms Employers Need to Know

Jan 12, 2018 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Pharmacy Benefit Managers
PBM contracts can be confusing and packed with jargon. Here’s what employers need to know to navigate their pharmacy benefits.
Read more ▸▸

5 Dos and Don’ts in Your New Copay Program’s First Weeks

Jan 5, 2018 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
The new year means a new copay program for many brand managers. Here are a few things to think about as you watch the results from your copay program come in.
Read more ▸▸

Your Cheat Sheet for Pharmacy Benefits

Dec 26, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
Pharmacy benefits can be confusing, with many moving parts. Our cheat sheet breaks down what you need to know to become wiser in the area of pharmacy benefits.
Read more ▸▸

Top 4 Myths of Pharmacy Benefits

Dec 26, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Pharmacy Benefit Managers
When it comes to pharmacy benefits, there's a lot of information out there — and a lot of misinformation. We present and debunk 4 myths about pharmacy benefits.
Read more ▸▸

Prescription Drug News of Note - December 2017

Dec 25, 2017 | Trends, Insights & Analysis
Each month, we round up the latest FDA approvals and regulations... FDA approves Lyrica CR capsules, Imprimis Pharmaceuticals announces alternative to Restasis
Read more ▸▸

Six Best Practices for Working with Self-Insured Businesses

Dec 20, 2017 | Trends, Insights & Analysis, Brokers, Pharmacy Benefit Managers
What advice can brokers give to their self-insured clients? Here are six best-practices for helping self-insured clients control costs and mitigate risk.
Read more ▸▸

Why collecting patient data may be the best thing for your brand

Dec 18, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Access Programs
When done correctly, collecting patient data can have a big impact on your brand. Here’s how to do it well.
Read more ▸▸

Three Ways to Enhance Your Patient Engagement Strategy

Dec 12, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Access Programs
Your pharmaceutical CRM has huge potential to drive patient engagement and lower abandonment rates. Targeted, timely messaging is the key to success.
Read more ▸▸

How a Dermatology Brand Increased Scripts and Revenue with a Data-Driven Copay Assistance Design

Dec 6, 2017 1:54:46 PM | Case Studies, Pharmaceutical Manufacturers, Copay Programs
When reversal rates were high, a dermatology brand used Truveris to reevaluate their copay program. Learn how Truveris helped them drive 75% more scripts.
Read more ▸▸

Pharmacy Carve Out: Why it Makes Sense for Employers

Nov 28, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Pharmacy Carve Out
Thinking about carving out your company’s pharmacy benefits? Here’s why a pharmacy carve-out might be right for your company.
Read more ▸▸

Prescription Drug News of Note - November 2017

Nov 28, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations... FDA approves Lyrica CR capsules, Imprimis Pharmaceuticals announces alternative to Restasis
Read more ▸▸

6 Steps to Achieve Launch Excellence

Nov 28, 2017 8:05:45 AM | White Papers, Pharmaceutical Manufacturers, Patient Access Programs
Launch excellence is critical to the success of a drug. Here’s how an optimized patient access strategy can help you get there.
Read more ▸▸

3 Ways to Use Copay Program Data to Reach Physicians

Nov 20, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
Copay program data can help your brand succeed in the physician’s office. Learn more on the Truveris blog.
Read more ▸▸

What is a Pharmacy Carve Out Plan?

Nov 14, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Pharmacy Carve Out
Employers are turning to pharmacy carve out plans as a solution to rising prescription drug costs. Here’s your primer on carving out pharmacy benefits.
Read more ▸▸

Is a $0 Copay the Right Strategy for Your Brand’s Copay Program?

Nov 13, 2017 3:19:25 PM | Case Studies, Pharmaceutical Manufacturers, Copay Programs
$0 copays can be an effective copay program strategy, but at what cost? If you’re contemplating a $0 copay for your brand, read our case study first.
Read more ▸▸

Truveris Ranks on Deloitte's 2017 #Fast500 List of Fastest-Growing Technology Companies

Nov 9, 2017 | Trends, Insights & Analysis
Deloitte announced that Truveris is one of the fastest growing technology companies in North America, reaching #205 on their annual Technology Fast 500 list.
Read more ▸▸

Truveris Ranked 205th Fastest Growing Company in North America on Deloitte’s 2017 Technology Fast 500™

Nov 9, 2017 4:23:46 PM | Press Releases
Truveris today announced it ranked 205th on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy-tech companies in North America. Truveris grew 499% percent during this period.
Read more ▸▸

Patient Segmentation: How to Lower Costs and Increase Market Share

Nov 6, 2017 1:59:33 PM | Case Studies, Copay Programs, Pharmaceutical Manufacturers
How Truveris increased one ophthalmology brand’s market share by 50 basis points through patient segmentation.
Read more ▸▸

How Truveris Helped the New Jersey Education Association Save $1.6 Billion

Nov 2, 2017 4:38:01 PM | Case Studies, Labor Unions, State & Public Employers, Pharmacy Benefit Managers
After a competitive PBM bidding process, the NJEA will now save $1.6 billion on a three-year PBM contract. Learn how Truveris technology made it possible.
Read more ▸▸

Creating PBM Transparency to Help a Large Airline Save Millions

Nov 2, 2017 4:32:52 PM | Case Studies, Enterprise Employers, Pharmacy Benefit Managers
PBM transparency from Truveris helped a large airline recover over $2 million and renegotiate a better deal on their existing PBM contract. Learn more.
Read more ▸▸

How a Large Telecom Company Saved Millions on their PBM Contract Without Switching PBMs

Nov 2, 2017 4:29:56 PM | Case Studies, Enterprise Employers, Pharmacy Benefit Managers
Truveris technology helped this large telecom company achieve major savings on their PBM contract. Download the case study to learn how your company can save.
Read more ▸▸

Six Places Your Copay Program can Provide Deeper Insights and Drive Success

Oct 30, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
Your copay program is generating a wealth of data, but do you know how and where to use it?
Read more ▸▸

What Anthem's new PBM, IngenioRx means for Brokers and Employers

Oct 23, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Pharmacy Benefit Managers
Anthem, Inc. announced that it is establishing a new pharmacy benefits manager (PBM) named IngenioRx. What does this mean for employers and brokers?
Read more ▸▸

Building a Better Patient Engagement Strategy

Oct 23, 2017 11:43:43 AM | Case Studies, Pharmaceutical Manufacturers, Patient Access Programs
When a dermatology brand’s patient engagement strategy wasn’t reaching patients, Truveris dug into the data to turn the program around. Get the case study.
Read more ▸▸

California’s Copay Coupon Bill Stirs Up Panic—Here’s What Pharmaceutical Brand Teams Need To Know.

Oct 16, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Prescription Drug News & Regulations - Pharma
How to navigate California's AB-265, a bill designed to curb the use of copay coupons for branded prescription drugs when a generic version is available.
Read more ▸▸

Prescription Drug News of Note - October 2017

Oct 15, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

4 Ways Providers Can Help Patients Save Money On Prescriptions

Oct 13, 2017 3:27:16 PM | White Papers, Pharmaceutical Manufacturers, Patient Access Programs
The rising price of medications is making it difficult or impossible for some patients to follow their provider’s orders.
Read more ▸▸

New Technology Breaks Down The Economic Barriers to Medication Adherence

Oct 13, 2017 3:21:57 PM | White Papers, Pharmaceutical Manufacturers, Patient Adherence
Medication non-adherence is becoming more of an issue as the price of medications continues to rise. However, this trend may be curbed with the help of new technologies.
Read more ▸▸

3 Ways The C-Suite Can Prepare For The Cadillac Tax

Oct 13, 2017 3:10:24 PM | White Papers, Enterprise Employers, Prescription Drug News & Regulations - Employers
Insurers and policymakers are dominating the discourse around the Cadillac Tax. But employers should be actively involved in the dialogue.
Read more ▸▸

Truveris Ranks on Crain's 2017 Fast 50 List of Fastest-Growing New York Companies

Oct 11, 2017 11:56:16 AM | News
Truveris was named to Crain's Fast 50 list of fastest growing companies in New York, with a notable growth rate of 501% powered by our innovative technology.
Read more ▸▸

Is Your Patient Abandonment Rate Really What You Think it is?

Oct 2, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Abandonment
Determining your brand’s true patient abandonment rate starts with understanding the data from key steps along the patient journey.
Read more ▸▸

Navigating Deductible Season

Sep 22, 2017 3:55:19 PM | Case Studies, Pharmaceutical Manufacturers, Patient Access Programs
How Truveris helped two unique brands navigate deductible season with targeted programs based on data and expert insights.
Read more ▸▸

How Artificial Intelligence in Healthcare is Helping Physicians Better Prescribe Treatments

Sep 21, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Medicine & Technology
The growing use of AI in healthcare is leading to more effective individualized treatments and greater patient access.
Read more ▸▸

Alysha Fluno Joins Truveris as Chief Pharmacy Officer

Sep 15, 2017 8:15:22 AM | News
Truveris announces the addition of Chief Pharmacy Officer Alysha Fluno, who will bring expertise from a diverse background in the pharmacy industry.
Read more ▸▸

Prescription Drug News of Note - September 2017

Sep 11, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Top 5 Copay Program Fallacies

Sep 8, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
There are many common misconceptions associated with designing or managing your copay program. Don’t be fooled by them, as they are likely hindering your performance.
Read more ▸▸

Truveris Secures $25 Million in New Funding to Help Reduce Cost and Improve Access to Prescription Medications

Sep 6, 2017 9:00:00 AM | Press Releases
McKesson Ventures led the funding round with existing investors to advance the company’s data and insights capabilities, which help manage rising prescription drug costs.
Read more ▸▸

Achieving a 12% Savings on a New PBM Contract

Sep 1, 2017 5:34:09 PM | Case Studies, Labor Unions, State & Public Employers, Pharmacy Benefit Managers
Achieving a 12% Savings on a New PBM Contract
Read more ▸▸

Why Technology is the Key to Empowering Healthcare Consumers

Sep 1, 2017 5:32:48 PM | Case Studies, Enterprise Employers, Pharmacy Benefit Managers
How OneRx Helps Consumers Save on Prescriptions
Read more ▸▸

How One Welfare Fund Saved on their PBM Renewal Rate

Sep 1, 2017 5:31:03 PM | Case Studies, Labor Unions, State & Public Employers, Pharmacy Benefit Managers
How One Welfare Fund Saved on their PBM Renewal Rate
Read more ▸▸

Is Your Copay Program Ready For 2018?

Aug 24, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
It’s after Labor Day and you have spent the summer carefully brand planning and strategically evaluating the tactics you need to put in place for 2017.
Read more ▸▸

Are You Considering The Right Segmentation Options For Your Copay Program?

Aug 24, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
When it comes to designing your copay program, chances are you haven’t considered all of the options.
Read more ▸▸

What is a Pharmacy Benefit Manager (PBM) and how Does a PBM Impact the Pharmacy Benefits Ecosystem?

Aug 15, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Pharmacy Benefit Managers
Pharmacy Benefits Managers play an important and often complicated role in the prescription benefits industry. Learn more on the Truveris blog.
Read more ▸▸

Is Your Copay Program Costing You More Than It’s Earning? Keep These Top 5 Metrics In Mind

Aug 11, 2017 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Copay Programs
While the strategy and goals of every copay program vary, we’ve found that the top 5 essential metrics to track ROI stay the same.
Read more ▸▸

State of New Jersey Cutting Prescription Drug Spend by 18% with Truveris TruBid® & Bill Review Technology

Aug 7, 2017 12:09:34 PM | Press Releases
The outcome of a contract between Truveris and the State of New Jersey to assist with reducing the State’s prescription drug spend will result in a savings of approximately 18%.
Read more ▸▸

Prescription Drug News of Note – August 2017

Aug 1, 2017 | Trends, Insights & Analysis, Enterprise Employers, Brokers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
A rundown of the latest FDA approvals and regulations from August 2017, with an expert take on what you need to know in the prescription drug industry.
Read more ▸▸

State Adopts Sweeney Plan To Save $1.5 Billion In Prescription Drug Costs

Jul 5, 2017 9:54:00 PM | News
New Jersey Senator Steve Sweeney's plan results in over $1 billion in savings for the state
Read more ▸▸

NJEA: Union-led Effort Nets $1.6 Billion in Prescription Savings

Jul 5, 2017 12:00:00 AM | News
Truveris reverse-auction technology helps the State of New Jersey save on prescription benefits cost.
Read more ▸▸

Wall Street Journal: Health-Care VCs Take Aim at High Drug Prices

Jun 8, 2017 12:00:00 AM | News
CEO Faisal Mushtaq shares his insights on how Truveris is bringing transparency to prescription drug pricing.
Read more ▸▸

Truveris Announces Appointment of Laurent Schockmel as Senior Vice President of Business Development

May 22, 2017 12:00:00 AM | News
Truveris announces appointment of Laurent Schockmel as senior vice president of business development.
Read more ▸▸

Jeff Ignaszak Joins Truveris as Chief Marketing Officer

May 17, 2017 12:00:00 AM | News
Jeff Ignaszak joins Truveris as chief marketing officer.
Read more ▸▸

Prescription Drug Prices Continue to Climb, Soaring 8.77% in Latest Truveris NDI Report

May 10, 2017 1:58:00 PM | Press Releases
Prescription drug prices soared 8.77% in 2016, representing the fourth consecutive year of inflation above 8%.
Read more ▸▸

Truveris Announces Appointment of Peter Day as Director of National Employer Sales

May 10, 2017 12:00:00 AM | News
Truveris announces appointment of Peter Day as Director of National Employer Sales.
Read more ▸▸

Truveris Selected by New Jersey to Implement Reverse Auction and Price Transparency Platform for Pharmaceutical Benefits

Apr 28, 2017 12:00:00 AM | News
Truveris selected by New Jersey to implement reverse auction and price transparency platform for pharmaceutical benefits.
Read more ▸▸

Truveris Strengthens Leadership Team with Appointment of Tim Herlehy as Chief Revenue Officer

Jan 9, 2017 12:00:00 AM | News
Truveris strengthens leadership team with appointment of Tim Herlehy as chief revenue officer
Read more ▸▸

The Keys To A Successful Partnership

Dec 12, 2016 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Access Programs
Use these five tips to create a productive relationship with your partner to ensure your copay program’s success.
Read more ▸▸

The Single Question You Are Missing From Your RFP

Nov 16, 2016 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Patient Access Programs
Selecting the right strategic partner can be a challenge and a Request for Proposal (RFP) is an important part of the selection process.
Read more ▸▸

Truveris Ranked Number 131 Fastest Growing Company in North America on Deloitte’s 2016 Technology Fast 500™

Nov 16, 2016 12:00:00 AM | News
Truveris Ranked Number 131 Fastest Growing Company in North America on Deloitte’s 2016 Technology Fast 500.
Read more ▸▸

Truveris to Participate in “62nd Annual Employee Benefits Conference”

Nov 3, 2016 12:00:00 AM | Events
Chief Pharmacy Officer Kristin Begley Pharm.D. will participate at an event, titled 62nd Annual Employee Benefits Conference.
Read more ▸▸

Truveris to Participate in “The Shift to Outcome-Based Care: Redefining how we Consume and Pay for Health Care”

Oct 31, 2016 12:00:00 AM | Events
Chief Pharmacy Officer Kristin Begley Pharm.D. will participate at The Shift to Outcome-Based Care: Redefining how we Consume and Pay for Health Care.
Read more ▸▸

Truveris to Participate in “23rd Annual Health & Benefits Expo”

Oct 3, 2016 12:00:00 AM | Events
Chief Pharmacy Officer Kristin Begley Pharm.D. will participate at an event, titled 23rd Annual Health & Benefits Expo hosted by Teamster Center Services.
Read more ▸▸

Truveris to Participate in “High Value Health: Making the Dream a Reality” Conference

Sep 23, 2016 12:00:00 AM | Events
Chief Pharmacy Officer Kristin Begley Pharm.D. will participate at High Value Health: Making the Dream a Reality hosted by NBCH.
Read more ▸▸

Truveris Strengthens Leadership Team with Appointment of Faisal Mushtaq as Chief Executive Officer

Sep 22, 2016 1:56:00 PM | Press Releases
Truveris, a leading provider of solutions across the prescription drug ecosystem, announced the appointment of Faisal Mushtaq as the chief executive officer.
Read more ▸▸

Truveris to Participate in “Strata + Hadoop World” Conference

Sep 20, 2016 12:00:00 AM | Events
Vice President of Data Science Joanne Chen will participate at an event, titled “Strata + Hadoop World” hosted by O’Reilly and Cloudera.
Read more ▸▸

Truveris to Participate in “Coupon and Co-Pay Offer Design Optimization” Conference

Sep 12, 2016 12:00:00 AM | Events
Vice President of Life Sciences Elizabeth Pattyn will participate at an event, titled “Coupon and Co-Pay Offer Design Optimization” hosted by CBI.
Read more ▸▸

Treato: Healthcare Insights Company Examines Patients’ Attitudes Towards Costs Related to Xtandi, Ibrance and Xarelto

Jul 19, 2016 12:00:00 AM | News
Treato announced that patients feel entitled to a drug discount program when prescribed a costly new drug
Read more ▸▸

EBN: Truveris' Bertrand Janin Ranked Amongst EBN’s 50 Benefit Technology Innovators

Jun 17, 2016 12:00:00 AM | News
As CTO of Truveris, Bertrand Janin oversees a team of engineers, product designers and analysts who create and maintain the healthcare startup’s products.
Read more ▸▸

How Can 340B Pricing Help Healthcare Organizations Save On Medications?

May 25, 2016 | Trends, Insights & Analysis, Pharmaceutical Manufacturers, Prescription Drug News & Regulations - Pharma
As prescription drug prices continue to increase, consumers are finding it increasingly difficult to pay for their medications.
Read more ▸▸

10 Questions Employers Should Be Asking About the Cadillac Tax

Apr 20, 2016 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
The Cadillac Tax is an excise tax levied on employers that provide high-cost health benefit plans to their employees.
Read more ▸▸

What Is A Single Source Generic And How Does It Impact Drug Pricing?

Apr 7, 2016 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Drug Pricing
Before signing up for any new insurance plan, you should familiarize yourself with an often overlooked segment of insurance – your pharmacy benefits plan.
Read more ▸▸

Exploring the Price of Medication

Mar 29, 2016 | Trends, Insights & Analysis, Consumers, Drug Pricing
Drug prices have increased dramatically over the past decade. But only 17 percent of consumers shop around for drugs to see if they can get better deal.
Read more ▸▸

Consumers Increasingly Walk Away from Prescription Drugs When Prices Reach $50, Creating Trend Toward Medication Abandonment, According to Truveris Data

Mar 22, 2016 1:55:00 PM | Press Releases
Consumers increasingly walk away from prescription drugs that treat medical conditions when prices reach the $50 threshold.
Read more ▸▸

How Do Genes Affect Drug Response?

Mar 16, 2016 | Trends, Insights & Analysis, Consumers, Medicine & Technology
Have you ever wondered why some medications work for certain people but not others? Why might you experience side effects from a drug while your friend doesn’t?
Read more ▸▸

Employee Benefit News: How Express Scripts is Looking to Hold Down Drug Prices

Mar 14, 2016 12:00:00 AM | News
According to the OneRx National Drug Index, in 2015 the cost of brand drugs was up 14.77%; specialty prices jumped 9.21% and generics cost 2.93% more.
Read more ▸▸

WLOS News 13: The Real Cost of Your Prescription and Why Shopping Can Save You Money

Mar 2, 2016 12:00:00 AM | News
Over the last year, prescription costs have shot up more than any other category of medical care.
Read more ▸▸

3 Novel Ways Medication May Impact Your Health

Mar 1, 2016 | Trends, Insights & Analysis, Consumers, Medicine & Technology
Drugs affect everyone differently. So when you’re prescribed a medication, what factors dictate how it will impact your health?
Read more ▸▸

Time: 13 Smart Ways to Save on Prescription Drugs

Feb 29, 2016 12:00:00 AM | News
Prescription-drug spending grew 12.2% in 2014—five times as fast as the year before—according to the Centers for Medicare & Medicaid Services.
Read more ▸▸

Pharmaceutical Executive: How Did Things Get This Bad? Look in the Mirror, US Pharma

Feb 29, 2016 12:00:00 AM | News
There has to be a lot of head-shaking going on in the C-suites of many U.S. pharmaceutical companies.
Read more ▸▸

Palm Beach Daily News: Island Pharmacists React to Rising Prescription Drug Costs

Feb 19, 2016 12:00:00 AM | News
The former Turing Pharmaceutical executive rose to international notoriety after his company raised the price of Daraprim by 5,000 percent.
Read more ▸▸

GOBankingRates: Over 40% of Americans Expect to Pay More for Healthcare in 2016

Feb 16, 2016 12:00:00 AM | News
Many of the most common health-related costs that Americans face increased over the course of 2015 or are set to increase in 2016.
Read more ▸▸

Pharmaceutical Processing: Brand Name Statins Still Favored by Consumers

Jan 27, 2016 12:00:00 AM | News
Treato, a leading consumer healthcare website, revealed their first annual list of top statins.
Read more ▸▸

Drug Store News: Patients still Prefer Brand-Name Statins

Jan 27, 2016 12:00:00 AM | News
The ranking shows that, despite widespread availability of generics for popular brand-name statins, patient satisfaction is higher with brand-name drugs.
Read more ▸▸

The Wall Street Journal: A New Prescription for Lower Drug Prices

Jan 25, 2016 12:00:00 AM | News
For three years in a row, according to a recent survey by health-care data company Truveris, prescription-drug prices in the U.S. have risen by double digits.
Read more ▸▸

Today’s Credit Unions: Prescription Drug Price Continue to Rise in Double Digits

Jan 24, 2016 12:00:00 AM | News
According to the latest figures from the OneRx National Drug Index, prescription drug prices rose 10.43% in 2015.
Read more ▸▸

The Palm Beach Post: West Palm Beach Doctor, Daughter Exposes Drug Price Hikes up to 1,700%

Jan 22, 2016 12:00:00 AM | News
Prices rose an average of 401 percent on 19 prescription drugs for skin conditions.
Read more ▸▸

Healthzette: Why You Can’t Afford Your Medication

Jan 15, 2016 12:00:00 AM | News
Prescription drug costs have been rising faster than general inflation.
Read more ▸▸

Talk Business & Politics: 11.3 Million Individuals Sign up for Obamacare Through Health Insurance Marketplaces

Jan 15, 2016 12:00:00 AM | News
More than 11.3 million people are signed up for coverage through the Health Insurance Marketplaces in all 50 states and the District of Columbia.
Read more ▸▸

The Daily Journal: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 13, 2016 12:00:00 AM | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

CBS News: ​Drugmakers Ring in 2016 with Hefty Price Hikes

Jan 12, 2016 12:00:00 AM | News
Drugmakers including Pfizer (PFE) and Allergan (AGN) have boosted prices on many brand-name medications since last month.
Read more ▸▸

FirstWord Pharma: Price of Prescription Drugs Rose over 10 Percent in US Last Year

Jan 12, 2016 12:00:00 AM | News
US prescription drug prices lifted 10.43 percent in 2015, with the cost of branded medicines jumping 14.77 percent.
Read more ▸▸

FiercePharma: What Public Outcry? New Year Brings Dozens of Double-Digit Drug Price Hikes

Jan 12, 2016 12:00:00 AM | News
The market researchers at Truveris have another update: Branded prescription drug prices went up 14.5% last year overall.
Read more ▸▸

The State Journal-Register: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 11, 2016 12:17:00 PM | News
Drug prices were big news in 2015, thanks in large part to Martin Shkreli, who drew outrage for hiking the price of a life-saving drug by 5,000 percent.
Read more ▸▸

The Washington Post: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 11, 2016 12:00:00 AM | News
Drug prices were big news in 2015, thanks in large part to Martin Shkreli, who drew outrage for hiking the price of a life-saving drug by 5,000 percent.
Read more ▸▸

The Columbus Dispatch: Drug Prices up More than 10 Percent in 2015

Jan 11, 2016 12:00:00 AM | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

Business Insurance: Prescription Drug Prices Jumped More than 10 Percent in 2015

Jan 11, 2016 12:00:00 AM | News
Drug prices were big news in 2015, thanks in large part to Martin Shkreli, who drew outrage for hiking the price of a life-saving drug by 5,000 percent.
Read more ▸▸

Specialty Pharma Journal: New Report Finds Prescription Drug Prices Rose 10.43 Percent in 2015

Jan 11, 2016 12:00:00 AM | News
Prescription drug prices rose 10.43 percent in 2015 – squeezing American household budgets and adding fuel to the debate around healthcare costs.
Read more ▸▸

Chicago Tribune: Prescription Drug Prices Jumped More than 10 Percent in 2015,

Jan 11, 2016 12:00:00 AM | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

St. Louis Post-Dispatch: Prescription Drug Prices Jumped More Than 10 Percent in 2015,

Jan 11, 2016 12:00:00 AM | News
Prescription drug prices rise more than 10 percent in 2015 well in excess of the U.S. inflation rate - according to an analysis released Monday by Truveris.
Read more ▸▸

InsuranceNewsNet: Prescription Drug Prices Climbed 10.43% in 2015

Jan 11, 2016 12:00:00 AM | News
Prescription drug prices rose 10.43 percent in 2015 – squeezing American household budgets and adding fuel to the debate around healthcare costs.
Read more ▸▸

Reuters: Pfizer Hikes U.S. Prices for Over 100 Drugs on January 1

Jan 8, 2016 12:00:00 AM | News
Pfizer Inc on Jan. 1 raised U.S. prices for more than 100 of its drugs, some by as much as 20 percent, according to statistics compiled by Wolters Kluwer.
Read more ▸▸

The Traverse City Record Eagle: No COLA Increase Should Infuriate and Energize Seniors

Oct 27, 2015 12:00:00 AM | News
About 65 million seniors were informed on Oct. 15 that there would be no Social Security annual cost of living adjustment (COLA) for 2016.
Read more ▸▸

American Journal of Managed Care: 2015 Sees a More Gradual Slope to Prescription Drug Prices

Oct 27, 2015 12:00:00 AM | News
A new analysis by the healthcare technology firm Truveris, reports that prescription drug prices rose 9.1% through September 30, 2015, for all medicines.
Read more ▸▸

Fortune: Why the Drug Price Scandal won’t be Enough to Keep Down Prices

Oct 26, 2015 12:00:00 AM | News
Daraprim captured national attention in September when Turing Pharmaceuticals boosted the price of the lifesaving toxoplasmosis treatment by over 5,000%.
Read more ▸▸

Pharmalot: Prescription Drug Price Hikes are Slowing this Year

Oct 26, 2015 12:00:00 AM | News
The price tags for prescription drugs are a red-hot issue that is increasingly causing concern among consumers, physicians and insurers.
Read more ▸▸

Drug Channels: Three Ways The C-Suite Can Prepare for the Cadillac Tax

Oct 23, 2015 12:00:00 AM | News
Leon discusses “the Cadillac tax,” a federal tax employers will pay on higher priced employee health benefit plans.
Read more ▸▸

Chief Executive: Pharma CEOs Grapple With Huge R&D Costs

Oct 22, 2015 12:00:00 AM | News
Turing Pharmaceuticals CEO Martin Shkreli hiked the price of Daraprim—a drug used to treat patients with AIDS, cancer, and malaria—by about 5,445%.
Read more ▸▸

TheStreet: Prescription Drug Costs Rising Again Even Among Generic Medications

Oct 21, 2015 12:00:00 AM | News
Prescription drug prices are expected to spike again, especially among some generic medications, following last year’s swift increase.
Read more ▸▸

MainStreet: Prescription Drug Costs Rise Again

Oct 21, 2015 12:00:00 AM | News
Prescription drug prices are expected to spike again, especially among some generic medications, following last year’s swift increase.
Read more ▸▸

USA Today: Stagnant Social Security Check Could Pose Hardship for Some

Oct 16, 2015 12:00:00 AM | News
Millions of Social Security recipients who depend on the program for most of their income will have to cut back on necessities such as food and medical care.
Read more ▸▸

Xconomy: Q&A with Biotech Venture Vet Nina Kjellson

Sep 30, 2015 12:00:00 AM | News
Nina Kjellson has been a biotech investor for 15 years, having spent the last 13 at InterWest Partners in Menlo Park, CA, and now moving to Canaan Partners.
Read more ▸▸

Fortune: Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach

Sep 29, 2015 12:00:00 AM | News
Drug prices have taken center stage since Turing Pharmaceuticals raised the price of its off-patent parasite-fighting drug Daraprim by over 5,000%.
Read more ▸▸

Mic: Hedge Fund Manager's Turing Pharmaceuticals Raises 62-Year-Old Drug From $13.50 to $750

Sep 21, 2015 12:00:00 AM | News
Daraprim used to cost just $13.50 per dose. Now it's $750 for each and every tablet.
Read more ▸▸

Truveris to Participate in “Analytics Experience 2016” Conference

Sep 5, 2015 12:00:00 AM | Events
Vice President of Data Science Joanne Chen will participate at an event, titled “Analytics Experience 2016” hosted by SAS Institute.
Read more ▸▸

CNBC: More Americans Cut Spending to Pay for Prescription Drugs

Aug 18, 2015 12:00:00 AM | News
One-third of Americans who regularly take prescription medication are seeing price hikes this year.
Read more ▸▸

New App Helps Consumers Find More Ways to Save on Prescription Drugs

Aug 5, 2015 1:46:00 PM | Press Releases
OneRx enables consumers to review drug pricing and benefits data, offering the most robust prescription drug savings tool in the marketplace.
Read more ▸▸

The Washington Post: How new drugs helping millions of Americans live longer are also making them go broke

Jun 30, 2015 12:00:00 AM | News
If you pay for good health insurance, shouldn’t you be able to afford the medicine you need?
Read more ▸▸

Employee Benefit News: Plan Design Changes Required to Curb Rising Rx Drug Prices

May 1, 2015 12:00:00 AM | News
Prescription drug prices jumped another 3.8% in the first quarter of 2015, adding to the fears of employers concerned about increasing health care costs.
Read more ▸▸

Employee Benefit News: Generic Drugs Beat Explosive Price Trends in Health Plans

May 1, 2015 12:00:00 AM | News
Generic pharmaceuticals have maintained their “laggard” status compared to branded and specialty drugs with respect to rising prices.
Read more ▸▸

Valued Pharmacy Services: 2015 Prescription Drug Prices Jump Another 3.8% in Q1, According to Truveris National Drug Index

Apr 29, 2015 12:00:00 AM | News
Truveris continues to spotlight prescription drug cost increases with 2015 data from the Truveris National Drug Index (NDI).
Read more ▸▸

2015 Prescription Drug Prices Jump Another 3.8% in Q1, According to Truveris National Drug Index

Apr 28, 2015 1:44:00 PM | Press Releases
Truveris continues to spotlight prescription drug cost increases with 2015 data from the Truveris National Drug Index (NDI).
Read more ▸▸

Life Health Pro: Stop-Loss, The Market Plumbers

Mar 20, 2015 12:00:00 AM | News
Some of the bigger small employers are thinking of stop-loss programs as a health benefits life raft.
Read more ▸▸

American Pharmacy News: Truveris Launches Pharmacy Stop Loss Insurance Platform

Mar 17, 2015 12:00:00 AM | News
Truveris introduces a new product that will enable benefits brokers and advisers to help companies take advantage of stop loss insurance.
Read more ▸▸

Truveris Launches Pharmacy Stop Loss Insurance Platform to Protect Employers from Rising Benefits Costs

Mar 17, 2015 12:00:00 AM | Press Releases
Truveris has introduced a new product to enable benefits brokers and advisors help companies more easily take advantage of stop loss insurance.
Read more ▸▸

Bloomberg News: The Drug Pipeline Flows Again

Feb 26, 2015 12:00:00 AM | News
One new drug, Bristol-Myers Squibb’s Opdivo, boosted one-year survival rates in trials to 73 percent from 42 percent for standard chemotherapy.
Read more ▸▸

Financial Times: The Race to Cure Rising Drug Costs

Feb 10, 2015 12:00:00 AM | News
Since contracting hepatitis C 25 years ago, Lucinda Porter’s biggest fear has been that she would infect someone else with the deadly virus. “Whenever I cut myself and saw the smeared blood, I would panic,” she says.
Read more ▸▸

Aging Care: Did You Notice the Big Jump in Drug Costs from 2013 to 2014?

Feb 3, 2015 12:00:00 AM | News
If you’re an average citizen who required prescription medication in 2014, you paid about 10.9 percent more than you did in 2013.
Read more ▸▸

Business Journal: Branded Drug Prices Spike 15 Percent

Jan 30, 2015 12:00:00 AM | News
Branded drug prices spiked nearly 15% last year, according to the latest data from the Truveris National Drug Index.
Read more ▸▸

FiercePharma: Branded Drug Prices Leapt Almost 15% Last Year, Led by Pain Pills, COPD and Heart Meds

Jan 29, 2015 12:00:00 AM | News
U.S. consumers saw prescription med prices vault 10.9% in 2014, according to the Truveris National Drug Index.
Read more ▸▸

Healthy Skeptic: Truveris Drug Price Index

Jan 28, 2015 12:00:00 AM | News
The Truveris National Drug Index gathers and publishes data on medication pricing.
Read more ▸▸

Clinical Informatics News: Drug Prices Rose Across Classes in 2014

Jan 28, 2015 12:00:00 AM | News
On Monday, the Truveris National Drug Index released its first full year figures. In 2014, generic and specialty drugs combined rising 10.9%.
Read more ▸▸

The Wall Street Journal: Prices for Prescription Medicines Rose How Much Last Year?

Jan 26, 2015 12:00:00 AM | News
The prices of prescription medicines is a front-and-center issue as the cost to treat everything from some of the rarest diseases to the most common afflictions is causing increasing concern among payers, physicians and consumers.
Read more ▸▸

Americans Faced Double Digit Increases in Prescription Drug Prices in 2014, According to Truveris National Drug Index

Jan 26, 2015 12:00:00 AM | Press Releases
Americans faced double-digit price increases for prescription medications in 2014, according to the Truveris National Drug Index.
Read more ▸▸

Truveris Debuts NDI National Drug Index

Nov 19, 2014 12:00:00 AM | Press Releases
Truveris Debuts NDI National Drug Index
Read more ▸▸

LA Times: What's behind the huge price jump for some generic drugs?

Oct 20, 2014 12:00:00 AM | News
That's a question many consumers have been asking lately. And now, a pair of prominent congressmen are demanding an answer from the drug industry.
Read more ▸▸

Truveris Launches RxChoice, the Industry’s First Pharmacy Benefit Marketplace

Sep 23, 2014 12:00:00 AM | Press Releases
Truveris Launches RxChoice
Read more ▸▸

Forbes: Delivering On Big Data For Verticals, Truveris Helps Pharmacy Industry Work Smarter

Aug 20, 2014 12:00:00 AM | News
The benefits that applying analytics to data has long been understood. But generally the big data solutions we’ve seen thus far have been targeted towards broad horizontal opportunities.
Read more ▸▸

Truveris launches RxDash, a Game-Changer that Allows Instant Price and Plan Design Modeling for Pharmacy Benefits Changes

Aug 20, 2014 12:00:00 AM | Press Releases
Truveris Launches RxDash
Read more ▸▸

Crain’s New York: Digital health startup rides funding wave

Jun 27, 2014 2:46:00 PM | News
Hudson Square-based Truveris becomes the latest beneficiary of the Obamacare-powered surge in funding for digital health care analysis, snagging $12.8 million in new capital.
Read more ▸▸

Pharmacy Pricing & Benefits Analysis Platform Truveris Raised Another $12.75M

Jun 27, 2014 12:00:00 AM | Press Releases
Truveris raises $12.8M in Series C
Read more ▸▸

TechCrunch: Prescription auditing service Truveris raises $12.75 million

Jun 26, 2014 9:50:00 PM | News
Bringing clarity to the $300 billion prescription drug payment system in the U.S., Truveris has raised $12.75 million in a new round of funding led by Canaan Partners.
Read more ▸▸